<- Go Home

TearLab Corporation

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. The company offers TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab Pen, a hand-held device that interfaces with the TearLab disposable; and TearLab Reader, a small desktop unit that allows for the docking of the TearLab Pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in Southlake, Texas.

Market Cap

$1.4M

Volume

34.6K

Cash and Equivalents

$7.3M

EBITDA

$767.3K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$14.3M

Profit Margin

64.76%

52 Week High

$0.21

52 Week Low

$0.02

Dividend

N/A

Price / Book Value

-0.03

Price / Earnings

-0.13

Price / Tangible Book Value

-0.03

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$128.0K

Return on Equity

22.78%

Return on Assets

0.54

Cash and Short Term Investments

$7.3M

Debt

$38.6M

Equity

-$27.6M

Revenue

$22.1M

Unlevered FCF

-$578.7K

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches